Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Musculoskeletal Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Connective and Soft Tissue Neoplasm
Musculoskeletal Neoplasm

Cancer Family

Musculoskeletal Neoplasm

CI-CAN-00000278Explore in graph →

Non-malignant212 active trials5 approved drugs54 evidence items

NCIt: C166354

Overview
Statistics
Survival
Genomics4
Variants & evidence54
Drugs8
Trials1088
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (40)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 26–40 of 40 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases.
· Mod Pathol · 2023 · PMID 37422156 · validated civic_curation pubmed
Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
· Cancer Med · 2020 · PMID 32087612 · validated civic_curation pubmed
Fusion events lead to truncation of FOS in epithelioid hemangioma of bone.
· Genes Chromosomes Cancer · 2015 · PMID 26173738 · validated civic_curation pubmed
Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.
· Genes Chromosomes Cancer · 2013 · PMID 23463663 · validated civic_curation pubmed
Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.
· Histopathology · 2021 · PMID 33382123 · validated civic_curation pubmed
Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings.
· Am J Surg Pathol · 2021 · PMID 33949344 · validated civic_curation pubmed
FOS-ANKH and FOS-RUNX2 Fusion Genes in Osteoblastoma.
· Cancer Genomics Proteomics · 2020 · PMID 32108038 · validated

Showing 26–40 of 40 publications

← Previous
1
2
Next →

civic_curation

Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing's sarcoma.

· Br J Cancer · 2015 · PMID 26291055 · validated civic_curation pubmed

Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.

· Clin Cancer Res · 2015 · PMID 26179511 · validated civic_curation pubmed

Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors.

· Cancer Res · 2009 · PMID 19366796 · validated civic_curation pubmed

PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability.

· Cancer Discov · 2017 · PMID 28446439 · validated civic_curation pubmed

Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy.

· PLoS One · 2017 · PMID 28672024 · validated civic_curation pubmed

de Wardin et al. JCO Precis Oncol 2023

· 2023 · PMID 37315267 · validated cbioportal_study pubmed

Wardin et at. NPJ Precis Oncol 2023

· 2023 · PMID 37730754 · validated cbioportal_study pubmed

Dermawan JK et al. Sci Adv 2026

· 2026 · PMID 41758938 · validated cbioportal_study pubmed